HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

i-cholesterol

structure given in first source

Also Known As:

3 alpha,5 alpha-cyclocholestan-6 beta-ol

Networked: 12 relevant articles (0 outcomes, 2 trials/studies)

Bio-Agent Context: Research Results

Polycyclic Compounds: 6
- Fused-Ring Compounds
  - Steroids: 70059
    - Cholestanes
      - Sterols: 2245
        Cholesterol: 67133
        i-cholesterol: 12
      - Cholestenes
        Cholesterol: 67133
        i-cholesterol: 12
Lipids: 114793
- Membrane Lipids: 1591
  - Sterols: 2245
    - Cholesterol: 67133
      - i-cholesterol: 12

Experts

1.	Anderson, Josephine L C: 1 article (01/2017)
2.	Gautier, Thomas: 1 article (01/2017)
3.	Nijstad, Niels: 1 article (01/2017)
4.	Schuchardt, Mirjam: 1 article (01/2017)
5.	Tietge, Uwe J F: 1 article (01/2017)
6.	Tölle, Markus: 1 article (01/2017)
7.	van der Giet, Markus: 1 article (01/2017)
8.	Baghel, Usha Singh: 1 article (01/2014)
9.	Bisen, P S: 1 article (01/2014)
10.	Mahajan, Sunil: 1 article (01/2014)

Related Diseases

1.	Stroke (Strokes) 01/01/2000 - "These beneficial effects are obtained from studies in middle aged patients with ischaemic heart disease, the interpretation being that the effects of HMG-CoA reductase inhibitors on stroke are mediated via (i) cholesterol-lowering effects on the coronary vasculature or (ii) cholesterol-independent effects of these agents. "
2.	Hypercholesterolemia 01/01/2001 - "Patients with type II hypercholesterolemia were enrolled in the study and instructed to continue a step I cholesterol-lowering diet for 6 weeks and those eligible to be included (89) were randomly allocated to receive under double-blind conditions placebo (n = 30), policosanol 20 mg/day (n = 29) or 40 mg/day (n = 30). "
3.	Heart Diseases (Heart Disease) 01/01/2000 - "These beneficial effects are obtained from studies in middle aged patients with ischaemic heart disease, the interpretation being that the effects of HMG-CoA reductase inhibitors on stroke are mediated via (i) cholesterol-lowering effects on the coronary vasculature or (ii) cholesterol-independent effects of these agents. "
4.	Stable Angina 01/01/2000 - "There were 102 males in group I (cholesterol < 200 mg/dL), 187 in group II (cholesterol 200-239 mg/dL), and 100 in group III (cholesterol > or = 240 mg/dL) and 49 females in group I and 41 in group II. The groups were evenly matched for age and numbers with stable angina or survivors of myocardial infarction. "
5.	Atherosclerosis 01/01/1985 - "Risk factors of clinical manifestations of atherosclerosis are compared in prospective studies, including the Paris Prospective Study I. Cholesterol and blood pressure are linked to the 3 manifestations of coronary heart disease (angina, infarction and sudden death), but tobacco is not linked to angina. "

Related Drugs and Biologics

1.	Cholesterol
2.	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)
3.	policosanol
4.	N 30
5.	Oleic Acid (Oleate)
6.	Triglycerides (Triacylglycerol)
7.	Phosphatidylcholines (Phosphatidylcholine)
8.	DNA (Deoxyribonucleic Acid)
9.	phosphatidylethanolamine
10.	oxidized low density lipoprotein

Related Therapies and Procedures

1.	Therapeutics